SCHEMBL18649792

SCHEMBL18649792

CCCN(C)CCSC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6272525 0.88 CA12 (0.39)
SCHEMBL13618850 0.84 S1PR2 (0.36)
SCHEMBL12853831 0.80
SCHEMBL129815 0.78
SCHEMBL17346405 0.78 CA12 (0.61)
SCHEMBL17346297 0.77 CYP2C9 (0.31)
SCHEMBL23065527 0.76
Hydrochloric Acid SCHEMBL22771623 0.75
SCHEMBL5715864 0.75 CA12 (0.53)
Ammonia Solution, Strong SCHEMBL9405419 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230339902-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2023-10-26 US disclosed
US-20230339902-A1 TRICYCLIC LIGANDS FOR DEGRADATION OF IKZF2 OR IKZF4 C4 THERAPEUTICS, INC. (US) 2023-10-26 US disclosed
US-9598396-B2 Tetrahydrophenanthridinones and tetrahydrocyclopentaquinolinones as PARP and tubulin polymerization inhibitors JANSSEN PHARMACEUTICA NV (BE) 2017-03-21 US disclosed